UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing

PLoS neglected tropical diseases, 2020-11, Vol.14 (11), p.e0008831

2020

Volltextzugriff (PDF)

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

Clinical pharmacokinetics, 2015-07, Vol.54 (7), p.677-690

2015

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C

Clinical pharmacokinetics, 2016-11, Vol.55 (11), p.1337-1351

2016

Volltextzugriff (PDF)

Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1182-1190

2018

Volltextzugriff (PDF)

Repair of Horizontal Meniscus Tears: A Systematic Review

Arthroscopy, 2014-11, Vol.30 (11), p.1513-1519

2014

Volltextzugriff (PDF)

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2429-2438

2012

Volltextzugriff (PDF)

Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib

Clinical pharmacokinetics, 2016-01, Vol.55 (1), p.33-45

2016

Volltextzugriff (PDF)

Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals

Journal of acquired immune deficiency syndromes (1999), 2018-08, Vol.78 (4), p.465-472

2018

Volltextzugriff (PDF)

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Emerging infectious diseases, 2020-09, Vol.26 (9), p.2168-2171

2020

Volltextzugriff (PDF)

Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir

Clinical pharmacokinetics, 2011-04, Vol.50 (4), p.229-244

2011

Volltextzugriff (PDF)

Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1191-1198

2018

Volltextzugriff (PDF)

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel

PloS one, 2011-10, Vol.6 (10), p.e25974

2011

Volltextzugriff (PDF)

Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function

Journal of acquired immune deficiency syndromes (1999), 2012-09, Vol.61 (1), p.32-40

2012

Volltextzugriff (PDF)

Bi-material terahertz sensors using metamaterial structures

Optics express, 2013-06, Vol.21 (11), p.13256-13271

2013

Volltextzugriff (PDF)

Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [ 14 C]-Labeled Microtracers with Separate Labeling Positions

Drug metabolism and disposition, 2023-12, Vol.51 (12), p.1607-1614

2023

Volltextzugriff (PDF)

Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir

Clinical pharmacokinetics, 2018-11, Vol.57 (11), p.1369-1383

2018

Volltextzugriff (PDF)

Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir

Clinical pharmacokinetics, 2016-05, Vol.55 (5), p.605-613

2016

Volltextzugriff (PDF)

Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial

The Journal of infectious diseases, 2010-03, Vol.201 (6), p.814-822

2010

Volltextzugriff (PDF)

Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens

JCI insight, 2020-06, Vol.5 (12)

2020

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment

Antimicrobial agents and chemotherapy, 2016-09, Vol.60 (9), p.5135-5140

2016

Volltextzugriff (PDF)

Larval tolerance to salinity in three species of Australian anuran: an indication of saline specialisation in Litoria aurea

PloS one, 2012-08, Vol.7 (8), p.e43427-e43427

2012

Volltextzugriff (PDF)

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition

Frontiers in molecular neuroscience, 2022-09, Vol.15, p.1001382-1001382

2022

Volltextzugriff (PDF)

Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3211-3221

2022

Volltextzugriff (PDF)

Carnal Hermeneutics

1st ed., 2015

Volltextzugriff (PDF)

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(333)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C

Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin

Repair of Horizontal Meniscus Tears: A Systematic Review

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib

Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir

Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine

A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel

Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function

Bi-material terahertz sensors using metamaterial structures

Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [ 14 C]-Labeled Microtracers with Separate Labeling Positions

Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir

Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir

Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial

Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects with Severe Renal Impairment

Larval tolerance to salinity in three species of Australian anuran: an indication of saline specialisation in Litoria aurea

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects

A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition

Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies

Carnal Hermeneutics

Suchergebnisse filtern